HS Code(s): 2941; 3003; 3004; 3005; (pharmaceutical products).
Public Consultation No. 1044, 8 April 2021. (13 page(s), in Portuguese). Draft: http://antigo.anvisa.gov.br/documents/10181/2695968/Minuta+1044.pdf/b63f7b1a-f316-4f7d-b12c-acecfbbc5bf
Public Consultation proposal to establish the criteria for the exemption and substitution of relative bioavailability and bioequivalence studies.